16 Apr 2012
The Introduction to Epigenetic Drug Discovery took place on 28 March at Cambridge HQ at the Chesterford Research Park. The event was well attended and the feedback received was very positive.
Available Conference Papers:
- Epigenetic regulators involved in cancer, Dr Mark Dawson, Cambridge Institute for Medical Research, UK
- Chemoproteomic approach to epigenetic drug targets, Dr Gerard Joberty, Cellzome, Germany
Does chromatin modification offer a superior approach to the treatment of chronic diseases?, Dr Chas Bountra, SGC, UK